Literature DB >> 14556633

Direct analysis of tubulin expression in cancer cell lines by electrospray ionization mass spectrometry.

Pascal Verdier-Pinard1, Fang Wang, Berta Burd, Ruth Hogue Angeletti, Susan Band Horwitz, George A Orr.   

Abstract

Differential expression of tubulin isotypes, mutations, and/or post-translational modifications in sensitive and Taxol-resistant cell lines suggests the existence of tubulin-based mechanisms of resistance. Since tubulin isotypes are defined by their C-terminal sequence, we previously described a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry-based analysis of tubulin diversity in human cell lines by analysis of their CNBr-released C-terminal peptides [Rao, S., Aberg, F., Nieves, E., Horwitz, S. B., and Orr, G. A. (2001) Biochemistry 40, 2096-103]. We now describe the liquid chromatography/electrospray ionization mass spectrometry analysis of native tubulins in Taxol-stabilized microtubules from parental and Taxol/epothilone-resistant human cancer cell lines. This method allows the direct determination of tubulin isotype composition, including post-translational modifications and mutations occurring throughout the entire protein. Four major isotypes, betaI-, betaIVb-, Kalpha1-, and alpha6-tubulin, were detected in two human carcinoma cell lines, A549 and HeLa. betaIII-Tubulin represented a minor species, as did alpha4-tubulin which was detected for the first time in both cell lines. The three alpha-tubulins were almost totally tyrosinated, and post-translational modifications were limited to low levels of monoglutamylation of Kalpha1-, betaI-, and betaIII-tubulin. betaII- and betaIVa-tubulins were not detected in either parental or drug-resistant cell lines, in contrast to previous RNA-based studies. Since mutations can occur in a single tubulin allele, the question as to whether the wild-type and mutant transcripts are both translated, and to what levels, is important. Heterozygous expression of Kalpha1- or betaI-tubulin mutants that introduced mass changes as small as 26 Da was readily detected in native tubulins isolated from Taxol- and epothilone-resistant cell lines.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14556633     DOI: 10.1021/bi0350147

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Evaluating reproducibility and similarity of mass and intensity data in complex spectra--applications to tubulin.

Authors:  Matthew T Olson; Paul S Blank; Dan L Sackett; Alfred L Yergey
Journal:  J Am Soc Mass Spectrom       Date:  2007-11-23       Impact factor: 3.109

Review 2.  Microtubule targeting agents: from biophysics to proteomics.

Authors:  D Calligaris; P Verdier-Pinard; F Devred; C Villard; D Braguer; Daniel Lafitte
Journal:  Cell Mol Life Sci       Date:  2010-01-28       Impact factor: 9.261

3.  All tubulins are not alike: Heterodimer dissociation differs among different biological sources.

Authors:  Felipe Montecinos-Franjola; Sumit K Chaturvedi; Peter Schuck; Dan L Sackett
Journal:  J Biol Chem       Date:  2019-05-20       Impact factor: 5.157

Review 4.  Methods in tubulin proteomics.

Authors:  Leah M Miller; Hui Xiao; Berta Burd; Susan Band Horwitz; Ruth Hogue Angeletti; Pascal Verdier-Pinard
Journal:  Methods Cell Biol       Date:  2010       Impact factor: 1.441

5.  Taxane pathway.

Authors:  Connie Oshiro; Sharon Marsh; Howard McLeod; Michelle Whirl Carrillo; Teri Klein; Russ Altman
Journal:  Pharmacogenet Genomics       Date:  2009-12       Impact factor: 2.089

6.  Characterization of a human βV-tubulin antibody and expression of this isotype in normal and malignant human tissue.

Authors:  Suzan K Chao; Yihong Wang; Pascal Verdier-Pinard; Chia-Ping H Yang; Lingling Liu; Alicia Rodriguez-Gabin; Hayley M McDaid; Susan Band Horwitz
Journal:  Cytoskeleton (Hoboken)       Date:  2012-07-02

7.  Phosphorylation of alpha6-tubulin by protein kinase Calpha activates motility of human breast cells.

Authors:  Thushara P Abeyweera; Xiangyu Chen; Susan A Rotenberg
Journal:  J Biol Chem       Date:  2009-04-29       Impact factor: 5.157

8.  Increased levels of a unique post-translationally modified betaIVb-tubulin isotype in liver cancer.

Authors:  Leah M Miller; Anuradha Menthena; Champak Chatterjee; Pascal Verdier-Pinard; Phyllis M Novikoff; Susan Band Horwitz; Ruth Hogue Angeletti
Journal:  Biochemistry       Date:  2008-06-21       Impact factor: 3.162

Review 9.  Tubulin proteomics: towards breaking the code.

Authors:  Pascal Verdier-Pinard; Eddy Pasquier; Hui Xiao; Berta Burd; Claude Villard; Daniel Lafitte; Leah M Miller; Ruth H Angeletti; Susan Band Horwitz; Diane Braguer
Journal:  Anal Biochem       Date:  2008-09-18       Impact factor: 3.365

10.  The roles of beta-tubulin mutations and isotype expression in acquired drug resistance.

Authors:  J Torin Huzil; Ke Chen; Lukasz Kurgan; Jack A Tuszynski
Journal:  Cancer Inform       Date:  2007-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.